Evaluation of the Effectiveness, Safety and Tolerability of LevoCept (Levonorgestrel-Releasing Intrauterine System) for Long-Acting Reversible Contraception

Trial Profile

Evaluation of the Effectiveness, Safety and Tolerability of LevoCept (Levonorgestrel-Releasing Intrauterine System) for Long-Acting Reversible Contraception

Recruiting
Phase of Trial: Phase II

Latest Information Update: 19 Feb 2017

At a glance

  • Drugs Levonorgestrel (Primary)
  • Indications Pregnancy
  • Focus Therapeutic Use
  • Sponsors ContraMed
  • Most Recent Events

    • 02 Dec 2016 According to a ContraMed media release, a total of six subjects were enrolled at the first two centers of the study till date.
    • 22 Nov 2016 Status changed from not yet recruiting to recruiting.
    • 14 Sep 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top